PKBDO6199LFVO
PKBDO6199LFVO
released
Clinical summary
Diabetes status
Type 2 Diabetes
BMI
35.4
HbA1c %
9.9
C-Peptide (ng/ml)
—
Diabetes duration
>10
Demographics
- Age (y)
- 50
- Gender
- Female
- Genetic Sex
- Female
- Ethnicity
- White
- Predicted genetic ancestry
- African (1%), Admixed-American (82%), East-Asian (1%), European (2%), South-Asian (14%)
Additional clinical
- Diabetes (ontology)
- T1D stage
- No sufficient information to derive
- Derived diabetes status
- Diabetes
- Family history of diabetes
- TRUE
- Family history relationship
- Father, Mother, Brothers
- Living donor
- No
- Cause of death
- Cerebrovascular/stroke
- Hospital stay (h)
- 124
- Medication
- Oral medications
HLA typing
Status: X/X
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 2 | 24 | OPO |
| B | 39 | 44 | OPO |
| C | 05 | 07 | OPO |
| Bw4 | 1 | — | OPO |
| Bw6 | 1 | — | OPO |
| DR | 4 | 14 | OPO |
| DR51 | 0 | — | OPO |
| DR52 | 1 | — | OPO |
| DR53 | 1 | — | OPO |
| DQ | 7 | 7 | OPO |
Data available
Islet
scRNAseqAccess dataset
Supplementary
IIDP
IIDP:SAMN10372788, HIPP:HIPP186
- Pancreas tissue available
- No
- Other tissues
- —
External resources
IIDP:SAMN10372788
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
